The Mayo Clinic experience in patients with metastatic melanoma who have failed previous pembrolizumab treatment.

Yiyi Yan,Jarrett J. Failing,Alexey A. Leontovich,Matthew S. Block,Robert R. McWilliams,Lisa A. Kottschade,Roxana S Dronca,Svetomir Nenad Markovic

The Mayo Clinic experience in patients with metastatic melanoma who have failed previous pembrolizumab treatment.

2016

Yiyi Yan
Jarrett J. Failing
Alexey A. Leontovich
Matthew S. Block
Robert R. McWilliams
Lisa A. Kottschade
Roxana S Dronca
Svetomir Nenad Markovic

e21014Background: Blockade of programmed death (PD-1) receptor has shown unprecedented rates of durable clinical responses in patients with metastatic melanoma. However, the majority of patients ev...

Keywords:

Melanoma
Physical therapy
Pembrolizumab
Medicine
metastatic melanoma
in patient
Oncology
Internal medicine
programmed death
Blockade
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations